VETOQUINOL EUR2.5 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0O1O for the last semiannual is 273.03 M EUR, and it's 6.55% higher compared to the previous semiannual. The net income of H2 23 is 23.33 M EUR.